Quick Answer
Picard Medical, Inc. reported Total Revenue of $4.94 million for fiscal year 2025.
Picard Medical, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Total Revenue | $4.94M +12.5% |
$4.39M | — |
| Revenue (ASC 606) | $4.94M +12.5% |
$4.39M | — |
| Net Income | -$27.00M -28.2% |
-$21.05M | — |
| Total Assets | $22.55M +86.3% |
$12.11M | — |
| Cash and Equivalents | $7.45M +7661.5% |
$96.0K | — |
| Stockholders Equity | $3.79M +108.6% |
-$44.00M -84.7% |
-$23.82M |
| R&D Expense | $3.05M -9.8% |
$3.38M | — |
| Operating Income | -$13.26M +3.3% |
-$13.71M | — |
| Gross Profit | -$204.0K -82.1% |
-$112.0K | — |
| Shares Outstanding | 73.70M +827.8% |
7.94M | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $1.19M | +34.7% | -44.3% |
| Revenue (ASC 606) | September 30, 2025 | $1.19M | +34.7% | +34.7% |
| Net Income | September 30, 2025 | -$10.43M | -68.0% | -55.1% |
| Total Assets | September 30, 2025 | $13.52M | — | +15.5% |
| Cash and Equivalents | September 30, 2025 | $2.81M | — | +586.1% |
| Stockholders Equity | September 30, 2025 | $7.97M | +122.5% | +114.6% |
| R&D Expense | September 30, 2025 | $951.0K | -1.0% | +28.0% |
| Operating Income | September 30, 2025 | -$3.49M | +21.5% | +1.0% |
| Gross Profit | September 30, 2025 | -$130.0K | +80.7% | -2.4% |
| Shares Outstanding | September 30, 2025 | 73.70M | — | +693.7% |
- Picard Medical, Inc. reported Total Revenue of $4.94 million for fiscal year 2025.
- Picard Medical, Inc. showed an increase of +12.5% in Total Revenue compared to the prior fiscal year.
- Picard Medical, Inc. reported Revenue (ASC 606) of $4.94 million for fiscal year 2025.
- Picard Medical, Inc. showed an increase of +12.5% in Revenue (ASC 606) compared to the prior fiscal year.
- Picard Medical, Inc. reported Net Income of -$27.00 million for fiscal year 2025.
- Picard Medical, Inc. showed a decrease of -28.2% in Net Income compared to the prior fiscal year.
- Picard Medical, Inc. reported Total Assets of $22.55 million for fiscal year 2025.
- Picard Medical, Inc. showed an increase of +86.3% in Total Assets compared to the prior fiscal year.
- Picard Medical, Inc. reported Cash and Equivalents of $7.45 million for fiscal year 2025.
- Picard Medical, Inc. showed an increase of +7661.5% in Cash and Equivalents compared to the prior fiscal year.
- Picard Medical, Inc. reported Stockholders Equity of $3.79 million for fiscal year 2025.
- Picard Medical, Inc. showed an increase of +108.6% in Stockholders Equity compared to the prior fiscal year.
- Picard Medical, Inc. reported R&D Expense of $3.05 million for fiscal year 2025.
- Picard Medical, Inc. showed a decrease of -9.8% in R&D Expense compared to the prior fiscal year.
- Picard Medical, Inc. reported Operating Income of -$13.26 million for fiscal year 2025.
- Picard Medical, Inc. showed an increase of +3.3% in Operating Income compared to the prior fiscal year.
- Picard Medical, Inc. reported Gross Profit of -$204.0 thousand for fiscal year 2025.
- Picard Medical, Inc. showed a decrease of -82.1% in Gross Profit compared to the prior fiscal year.
- Picard Medical, Inc. reported Shares Outstanding of 73.70 million shares for fiscal year 2025.
- Picard Medical, Inc. showed an increase of +827.8% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: